DailyStocks.com

Sign up   Log In
Lost Password?
MyDailyStocks
Set Home Page
What's New
Site Map
Help
FAQ
  
GLOSSARY STOCK ANALYSIS INSIDER BUYS PRODUCT REVIEWS EDUCATION SEARCH
Symbol:
Bookmark and Share

MARKET WATCH
DayTrading Portal
Free Stock Charts
Free Technical Analysis
REVIEWS
Online Brokers Review 2014
Investors Daily
Top 20 Baby Boomer WebSites
SEARCH ENGINES
Online Courses
Financial Advisers
SEC filings
Finance Jobs
Brand Reviews Only
Start-up Content Only
Enter Ticker symbol?

Ticker:CGTK
Company Name: Corgentech Inc.

Business Overview from 10-K filing for Corgentech Inc.:

Corgentech is creating a pipeline of novel therapeutics based on our proprietary transcription factor decoy, or TF decoy, technology. We evaluated our lead product candidate, E2F Decoy, a combination drug and delivery device, in two Phase 3 clinical trials during 2004 for the prevention of vein graft failure. The first of the two Phase 3 trials, called PREVENT III, which evaluated E2F Decoy in patients undergoing peripheral bypass graft surgeries (in the leg), did not meet its primary or secondary endpoints. The second of the two Phase 3 trials, called PREVENT IV, is evaluating patients undergoing coronary artery bypass graft, or CABG, surgeries. We and our collaboration partner, Bristol-Myers Squibb Company, or BMS, are planning to meet by the end of March 2005 with the Food and Drug Administration, or FDA, prior to unblinding the data from PREVENT IV.     

View the full CGTK chart at Wikinvest

For more information for Corgentech Inc., click on:
DailyStocks' Ticker-based links
DailyStocks' Technical Opinion
DailyStocks' Chart
DailyStocks' Quote with Technicals
DailyStocks' Profile
DailyStocks' PowerRating


Content Library
News
Insider Buys and Activist Buys
RESEARCH
Stock Search Engine
Guide to Financial Sites
FAQ
Investors Research Portal
Glossary
Company Overviews
Forums
Work with DailyStocks
License our Glossary
Write for us
About us
Feedback
Partners & Sponsors
InvestingChannel
COPYRIGHT© 1997-2012 DailyStocks. All Rights Reserved. Privacy Policy.
Link to this page http://www.dailystocks.com/companyoverviews/CGTK.htm, notify us and we will consider your web site to our directory